Viewing nowCombinationActoZone Met Tablets 15/850 mg
Metformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.

MFDS item code 201907392 · Approved 2019.10.22 · Insurance code 645406120
Improvement of blood sugar control in type 2 diabetes
This medication helps control blood sugar levels in patients with type 2 diabetes when used in conjunction with diet and exercise, aiding in effective blood sugar management.
The dosage of this medication should be individualized based on the efficacy and tolerability, not exceeding the maximum doses for each active ingredient, which are 30 mg of Pioglitazone and 2500 mg of Metformin. The initial dose should be based on the patient's current treatment regimen, starting with one tablet daily for patients receiving monotherapy with Metformin or Pioglitazone, evaluating therapeutic response and gradually adjusting the dosage. For patients switching from combination therapy of Pioglitazone and Metformin,
This medication assists in controlling blood sugar levels. It can cause a rare but severe condition known as lactic acidosis, so patients with impaired kidney function or heart disease should exercise particular caution. Additionally, patients with impaired liver function or those who consume excessive alcohol should avoid this medication, as it may pose risks. This medication can exacerbate heart issues such as congestive heart failure, so individuals with symptoms of heart failure or severe heart conditions should not use it. If there is a history of bladder cancer or symptoms related to the bladder (such as hematuria or urinary dysfunction), immediate consultation with a physician is necessary, and bladder cancer patients should refrain from taking this medication. For patients with diminished kidney function or at risk of acute kidney failure, administration of this medication should be discontinued or used cautiously, with regular kidney function tests required. This medication may cause hypoglycemia, particularly when taken with other blood sugar-lowering agents, so careful monitoring of blood sugar changes is advised. If undergoing surgery or receiving testing involving contrast agents, temporarily discontinue this medication and resume only after confirming normal kidney function. Pregnant or nursing women should not take this medication, and safety in pediatric patients has not been established. Elderly patients have a higher risk of worsened kidney function, thus dosage should be adjusted carefully and kidney function should be monitored regularly. While taking this medication, maintain regular meals and appropriate exercise, and have regular blood sugar and blood tests done. In the event of an overdose, seek immediate medical assistance, and blood dialysis may be necessary.
Severe lactic acidosis, hypoglycemia, symptoms of heart failure and congestive heart failure, severe edema, urinary abnormalities, cardiac abnormalities, severe liver failure, jaundice, severe allergic reactions, serious neurological symptoms, acute kidney function decline, kidney failure, bladder cancer, severe dermatological reactions, high fever with severe rashes and blisters, oral/ocular mucosal pain, breathing difficulties, asthma attacks, seizures, confusion, vision disturbances, paralysis, decreased urine output.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and humidity, so it must be stored in a sealed container. It's recommended to keep the storage temperature between 1 and 30 degrees Celsius to safely maintain the medication's efficacy.
White to grayish-white oblong film-coated tablets
30 tablets/PPT[(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
Pioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Dalim Biotech Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Metformin Hydrochloride · Pioglitazone Hydrochloride
Prescription medication · Combination
Nexpam Korea Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Ilhwa Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.